NAV

N,N'-diphenyl-1,4-phenylenediamine

This drug entry is astuband has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
N,N'-diphenyl-1,4-phenylenediamine
DrugBank Accession Number
DB14192
Background

Not Available

Type
Small Molecule
Groups
Approved, Experimental
Synonyms
Not Available

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information oncontraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including:blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRsBrowse all" title="" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

Interactions

Drug InteractionsLearn More" title="" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
这些信息不应该被解释the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
No interactions found.

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image
T.R.U.E. Test Thin-Layer Rapid Use Patch Test N,N'-diphenyl-1,4-phenylenediamine(25 ug/48h)+2,2'-Dibenzothiazyl disulfide(20 ug/48h)+2-mercaptobenzothiazole(61 ug/48h)+4-(Isopropylamino)diphenylamine(10 ug/48h)+Bacitracin(486 ug/48h)+Balsam of Peru(648 ug/48h)+Benzocaine(378 ug/48h)+Benzylparaben(162 ug/48h)+Bisphenol A diglycidyl ether(32 ug/48h)+Bromothalonil(4 ug/48h)+Bronopol(203 ug/48h)+Budesonide(0.8 ug/48h)+Butylparaben(162 ug/48h)+Chlorquinaldol(77 ug/48h)+Cinchocaine hydrochloride(66 ug/48h)+Cinnamaldehyde(41 ug/48h)+Cinnamyl alcohol(63 ug/48h)+Clioquinol(77 ug/48h)+Cobalt chloride hexahydrate(4 ug/48h)+Diazolidinylurea(446 ug/48h)+Potassium dichromate(15.7 ug/48h)+Dipentamethylenethiuram disulfide(5.5 ug/48h)+Diphenylguanidine(68 ug/48h)+分散蓝106(41 ug/48h)+Disulfiram(5.5 ug/48h)+Ditiocarb zinc(68 ug/48h)+Ethyl hydroxybenzoate(162 ug/48h)+Ethylenediamine(18 ug/48h)+Eugenol(41 ug/48h)+Evernia prunastri(81 ug/48h)+Formaldehyde(146 ug/48h)+Geraniol(81 ug/48h)+Hydrocortisone butyrate(16 ug/48h)+Hydroxycitronellal(63 ug/48h)+Imidurea(486 ug/48h)+Isoeugenol(17 ug/48h)+Lanolin alcohols(810 ug/48h)+Methylchloroisothiazolinone(3 ug/48h)+Methylparaben(162 ug/48h)+Morpholinylmercaptobenzothiazole(20 ug/48h)+N-Cyclohexyl-N'-phenyl-1,4-phenylenediamine(25 ug/48h)+Neomycin sulfate(486 ug/48h)+Nickel sulfate hexahydrate(36 ug/48h)+Parthenolide(2 ug/48h)+Propylparaben(162 ug/48h)+Quaternium-15(81 ug/48h)+Rosin(972 ug/48h)+Sodium aurotiosulfate(23 ug/48h)+Tetracaine hydrochloride(66 ug/48h)+Tetramethylthiuram monosulfide(5.5 ug/48h)+Thimerosal(6 ug/48h)+Thiohexam(20 ug/48h)+Thiram(5.5 ug/48h)+Tixocortol pivalate(2 ug/48h)+Zinc dibutyldithiocarbamate(68 ug/48h)+alpha-Amyl cinnamaldehyde(17 ug/48h)+p-Phenylenediamine(65 ug/48h)+p-tert-Butylphenol-formaldehyde resin (low molecular weight)(36 ug/48h) Kit Cutaneous SmartPractice Denmark ApS 2012-03-01 Not applicable US flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
DD517SCM92
CAS number
74-31-7
InChI Key
Not Available
InChI
Not Available
IUPAC Name
Not Available
SMILES
Not Available

References

General References
Not Available
RxNav
1363709

Clinical Trials

Clinical TrialsLearn More" title="" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Form Route Strength
Kit Cutaneous
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created at July 03, 2018 21:24 / Updated at June 22, 2021 18:16